Application Sponsors
ANDA 091641 | PHARMACARE LTD | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | CAPSULE;ORAL | 150MG | 0 | ATAZANAVIR | ATAZANAVIR |
002 | CAPSULE;ORAL | 200MG | 0 | ATAZANAVIR | ATAZANAVIR |
FDA Submissions
Submissions Property Types
CDER Filings
PHARMACARE LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 91641
[companyName] => PHARMACARE LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ATAZANAVIR","activeIngredients":"ATAZANAVIR","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"ATAZANAVIR","activeIngredients":"ATAZANAVIR","strength":"200MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ATAZANAVIR","submission":"ATAZANAVIR","actionType":"150MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"ATAZANAVIR","submission":"ATAZANAVIR","actionType":"200MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)